Globe Newswire

MENLO PARK, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (the “Company” or “Runway Growth”) a specialty finance company focused on providing senior secured loans to high growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products and other high-growth industries, today announced a proposed underwritten secondary offering of... (continue reading...)

• Q1 2024 Revenue of $22.9 million
• Q1 2024 Net loss of $5.9 million
• Q1 2024 Adjusted EBITDA loss of $0.0 million

All figures are reported in United States dollars ($) unless otherwise indicated

LAS VEGAS, May 09, 2024 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended... (continue reading...)

VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or the “Company”) announces the upcoming retirement of Michael Halvorson and Charles Oliver as part of the Company’s board succession plan and welcomes Tara Hassan as a new board nominee.

Board Succession

Mr. Halvorson, who has been a director of the Company since 2009 and Chair of the board since 2018, has announced to the Company... (continue reading...)

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. (“SSIC” or the “Company”) (NASDAQ: SSIC), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the first quarter ended March 31, 2024.

Quarter Ended 3/31/24 Highlights

• Total investment income of $2.8 million
• Net investment income (loss) of $(0.1) million, or $(0.01) per share
• Investment portfolio of... (continue reading...)

Presentations highlight data supporting FILSPARI® (sparsentan) as a foundational therapy over historical RASi standard of care and in newly diagnosed patients with IgAN

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the National Kidney Foundation (NKF) Spring Clinical Meetings in Long Beach, California, May 14-18, 2024, and the European... (continue reading...)